Source: Annual Congress 2011 - Treatments for pulmonary hypertension in human and experimental models
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Church, A. Mahmood, C. McSharry, D. Xu, A. Peacock, D. Welsh (Glasgow, United Kingdom). A role for ST2/IL-33 signalling in fibroblast proliferation utilising a novel transgenic mouse model of pulmonary hypertension. Eur Respir J 2011; 38: Suppl. 55, 408

Member's Comments

No comment yet.

Related content which might interest you: Elucidating signalling pathways in pulmonary hypertension using a microRNA knockout mouse model – In vitro and in vivo data Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 TSC1/mTOR pathway promotes hypoxia-induced pulmonary hypertension in mice Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 PBI-compound, a novel first-in-class anti-fibrotic compound, inhibits CTGF and collagen production in murine and human fibroblasts, and reduces lung fibrosis in the bleomycin-induced lung fibrosis model Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 miR-146a-5p plays an essential role in the aberrant epithelial–fibroblast cross-talk in COPD Source: Eur Respir J, 49 (5) 1602538; 10.1183/13993003.02538-2016 Year: 2017 c-Met expression induction in immune cells modulates pulmonary fibrosis progression Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 Follistatin-like 1 promotes intermittent hypoxia-induced lung fibroblast activation in vitro and in vivo Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 P38 signalling pathway in primary cultures of human bronchial epithelial cells: effects of transforming growth factor-β and pharmacological modulation by budesonide Source: Eur Respir J 2002; 20: Suppl. 38, 571s Year: 2002 LSC 2010 Abstract: Protease-activated receptor-2 plays a pivotal role in pulmonary fibrosis by inducing myofibroblast differentiation and tissue factor up-regulation Source: Annual Congress 2010 - Stem cells and growth factors in lung injury Year: 2010 p53-dependent, replicative cell senescence suppresses chronic hypoxia-Induced pulmonary hypertension in mice Source: Annual Congress 2011 - Pathobiology of experimental pulmonary hypertension Year: 2011 Reactivation of developmental pathways in idiopathic pulmonary fibrosis: FGF9 and FGF18 modulate the phenotype of control and fibrotic human lung fibroblasts in vitro Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Is TGFb a central mediator in the development of pulmonary fibrosis? Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar Year: 2010 Fibroblast growth factors induce proliferation of cultured human airway smooth muscle cells: autocrine role in the pathogenesis of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 78s Year: 2001 Genetic targeting of the pulmonary epithelium: the role of TGF-b and wnt signaling in ontogeny of specialized cell types Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009 Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension Source: Eur Respir J 2016; 48: 1137-1149 Year: 2016 The effect of ASK1 inhibition on hypoxia-induced pulmonary artery fibroblast activation and associated paracrine effects on vascular smooth muscle cells Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Hypoxia-induced pulmonary artery fibroblast proliferation and migration is prevented by ASK1 inhibition in an in vitro cellular model of pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Cell specific gene transfer of hepatocyte growth factor reduces bleomycin-induced lung fibrosis by inhibition of partial EMT Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon Year: 2008 Oral presentation: Protease-activated receptor-2 plays a pivotal role in pulmonary fibrosis by inducing myofibroblast differentiation and tissue factor up-regulation Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung Year: 2010 17(R)-resolvinD1 mediates a pathway involving the transcription factor c-Fos to reduce bleomycin-induced pulmonary fibrosis in mice. Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias Year: 2018